Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

MRAM vs AKTS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

MRAM Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 8–2 Matrix Metrics)

MRAM Overall Winner 6-Pillar Tally: MRAM 6 – 0 AKTS Matrix Metrics: MRAM 8 – 2 AKTS

As of Nov 16, 2026, Everspin Technologies, Inc (MRAM) is the stronger overall head-to-head candidate over AKTS (AKTS) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). MRAM carries a Unified Composite Score of 54.4/100 (HOLD) at $11.31 (21.3x Forward P/E, -23.3% operating margin), whereas AKTS carries 30.6/100 (SELL) at $16.49 (N/M Forward P/E, N/A operating margin).

  • Technical & Structure Timing Caution: MRAM is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 38.7); meanwhile AKTS trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 48.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About MRAM vs AKTS
MRAM NASDAQ Head-to-Head Winner
Everspin Technologies, Inc
Semiconductors & Related Devices
$11.31
-7.67% 1D
Market Cap $296.9M
TTM Revenue $69M
Forward P/E 21.3x
Beta / 30D Vol 4.50β · 107% Vol
Unified Composite Score
54.4 / 100 HOLD
Tech 50.0 Fund 60.0 Flow 69.0 Mom 78.9
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -9.8%), weak momentum, RSI 39
RSI-14: 38.7 · SMA20: $12.95 · SMA50: $15.00
AKTS US Equity
AKTS
Institutional Equity
$16.49
-0.78% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.36β · 66% Vol
Unified Composite Score
30.6 / 100 SELL
Tech 20.0 Fund 36.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 48
RSI-14: 48.1 · SMA20: $16.12 · SMA50: $18.33

6-Pillar Scorecard Institutional Category Breakdown (MRAM 6 – 0 AKTS)

Columns: Metric · MRAM · AKTS
1. Valuation Multiples MRAM
Forward P/E 21.3x N/M
Trailing P/E 19.6x N/M
PEG Ratio N/M N/M
EV / Revenue 4.3x N/M
2. Growth & Scale MRAM
Revenue Growth (YoY) +46.9% N/A
Earnings Growth (YoY) -10.8% N/A
TTM Revenue (USD) $69M N/A
Market Cap $296.9M N/A
3. Profitability & Quality MRAM
Gross Margin 52.2% N/A
Operating Margin -23.3% N/A
Net Profit Margin -14.3% N/A
Return on Equity (ROE) -14.8% N/A
4. Balance Sheet & Cash Flow MRAM
Cash Generation (TTM) -$15M EBITDA N/A
Cash Flow Margin -21.9% EBITDA Mgn N/A
Net Cash / Leverage $2.77 Book/Sh · -14.8% ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning MRAM
Options Structure Phase BREAKDOWN UNCLASSIFIED
Current IV / %ile 95.4% (29th %ile) N/A (N/A)
Put/Call OI Skew 1.72x (Put-Skewed) N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat MRAM
OpEx & R&D Intensity 75.5% of Rev ($52M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Semiconductors Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: MRAM (8) vs AKTS (2)
Institutional Metric MRAM AKTS Criterion Row Edge
Market Capitalization
Scale
$296.9M N/A Larger Scale MRAM
Trailing P/E Ratio
Valuation
19.6x N/M Lower Multiple MRAM
Forward P/E Ratio
Valuation
21.3x N/M Lower Multiple MRAM
Revenue Growth (YoY)
Growth
+46.9% N/A Higher Growth MRAM
Operating Margin (TTM)
Profitability
-23.3% N/A Higher Margin MRAM
Net Profit Margin
Profitability
-14.3% N/A Higher Margin MRAM
Return on Equity (ROE)
Capital Efficiency
-14.8% N/A Higher ROE MRAM
52-Week Range Position
Momentum
9% ($7–$52) 12% ($14–$34) Stronger Trend AKTS
Beta / 30D Volatility
Risk Regime
4.50β · 107% Vol 1.36β · 66% Vol Lower Realized Risk AKTS
Unified Institutional Score
Composite Signal
54.4 / 100 (HOLD) 30.6 / 100 (SELL) Higher Composite MRAM
Trailing 12M Revenue (USD)
Operating Scale
$69M N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
52.2% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 4.3x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$15M EBITDA ($2.77 Book/Sh · -14.8% ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon AKTS +22.63 pp
MRAM: -13.13% · AKTS: +9.5%
3M Horizon AKTS +4.66 pp
MRAM: -38.7% · AKTS: -34.04%
6M Horizon AKTS +54.7 pp
MRAM: -66.09% · AKTS: -11.39%
1Y Horizon MRAM +20.47 pp
MRAM: -5.91% · AKTS: -26.38%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MRAM vs AKTS. Trailing 12-month operating profitability (MRAM -23.3% vs AKTS N/A) and valuation multiples (MRAM 21.3x vs AKTS N/M Forward P/E) are benchmarked directly in Pillar 4 below.

MRAM ADR TTM Benchmark FX-Normalized USD
TTM Revenue$69M
Gross Margin52.2%
Op. Margin-23.3%
ROE / Fwd P/E-14.8% · 21.3x
AKTS ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
MRAM BREAKDOWN
130d in phase · OBV NEUTRAL
Current IV 95.4%
IV Percentile 29th %ile
Put/Call OI Skew 1.72x (Put-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact MRAM Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
AKTS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact AKTS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
MRAM Moat Profile Cyclical / Execution-Driven Positioning
Semiconductors Operator
Competes within the Semiconductors value chain with $296.9M market capitalization and -23.3% operating margin.
OpEx & R&D Reinvestment 75.5% of Rev ($52M)
90D Engineering Disclosures 0 Published
Mapped Supply-Chain Ecosystem (18 partners):
GLOBALFOUNDRIES Taiwan Semiconductor Manufacturing Company Tower Semiconductor ASE Technology Holding
AKTS Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ MRAM vs AKTS Key Questions & Quantitative Answers

As of Nov 16, 2026, Everspin Technologies, Inc (MRAM) is the stronger overall head-to-head candidate over AKTS (AKTS) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). MRAM carries a Unified Composite Score of 54.4/100 (HOLD) at $11.31 (21.3x Forward P/E, -23.3% operating margin), whereas AKTS carries 30.6/100 (SELL) at $16.49 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: MRAM is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 38.7); meanwhile AKTS trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 48.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

MRAM leads the Growth & Scale pillar: MRAM posts +46.9% YoY revenue growth and -10.8% YoY earnings growth on $69M TTM revenue (52.2% gross margin, -23.3% operating margin), compared with AKTS at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, MRAM generates $69M in USD-normalized revenue versus N/A for AKTS. In operating R&D and SG&A reinvestment, MRAM deploys 75.5% of Rev ($52M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for AKTS.

MRAM screens cheaper on headline valuation multiples. MRAM trades at 21.3x Forward P/E, 19.6x Trailing P/E, N/M PEG, and 4.3x EV/Revenue (-21.9% EBITDA margin), whereas AKTS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MRAM (-14.8% ROE) versus AKTS (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, MRAM carries 95.4% implied volatility (29th %ile, Balanced (25th–60th %ile)), a 1.72x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (4.50β · 107% Vol realized risk). By comparison, AKTS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.36β · 66% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.